Downregulation of microRNA‐100/microRNA‐125b is associated with lymph node metastasis in early colorectal cancer with submucosal invasion
0303 health sciences
TOR Serine-Threonine Kinases
Receptors, Somatomedin
X-Linked Inhibitor of Apoptosis Protein
Original Articles
HCT116 Cells
Matrix Metalloproteinases
Receptor, IGF Type 1
3. Good health
MicroRNAs
03 medical and health sciences
Cell Movement
Cell Line, Tumor
Lymphatic Metastasis
Humans
RNA Interference
fas Receptor
RNA, Small Interfering
Colorectal Neoplasms
HT29 Cells
Cell Proliferation
DOI:
10.1111/cas.13152
Publication Date:
2016-12-29T14:37:31Z
AUTHORS (13)
ABSTRACT
A majority of early colorectal cancers ( CRC s) with submucosal invasion undergo surgical operation, despite a very low incidence lymph node metastasis. Our study aimed to identify micro RNA s (mi specifically responsible for metastasis in s. Micro microarray analysis revealed that miR‐100 and miR‐125b expression levels were significantly lower tissues metastases than those without metastases. These results validated by quantitative real‐time PCR larger set clinical samples. The transfection or inhibitor into colon cancer HCT 116 cells increased cell invasion, migration, MMP activity. Conversely, overexpression mimics attenuated all these activities but did not affect growth. To target m s, we undertook gene array miR‐100‐silenced as well negative control cells. Ingenuity Pathway Analysis, TargetScan software analyses, subsequent verification identified mammalian rapamycin (m TOR ) insulin‐like growth factor 1 receptor IGF 1R) direct, Fas X‐linked inhibitor‐of‐apoptosis protein XIAP indirect candidate targets involved Knockdown each si reduced the invasiveness data clearly show downregulation is closely associated through enhancement motility, In particular, may promote upregulating , 1R, Fas, targets. Thus, be novel biomarkers invasion.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (28)
CITATIONS (32)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....